Hepatitis: all 3,372 studies

Page 13 of 34. Open to participants first (195), then studies with results posted, then the rest; newest registration first within each.

• Tenofovir Alafenamide Switching Therapy in Kidney or Liver Transplant Recipients With Chronic HBV InfectionActive, not recruitingNCT05410496Phase 4
• Effects of Antiviral Therapy on Patients With HBV-related HCCCompletedNCT05406089
• Utilization of Hepatitis B Virus NAT+ Donors for Hepatitis B Vaccinated Lung Transplant CandidatesWithdrawnNCT05404919Phase 2
• Evaluating the Chain of Addiction Care (CAC)Status unknownNCT05401136
• Prevalence and Burden of Hepatitis D Virus Infection in China Through Preoperative Examination Test (Predict Study)Status unknownNCT05394623
• Evaluation Freethiadine Tolerance in Healthy Subjects and Patients With Chronic Hepatitis B, Pharmacokinetics Characteristics and Antiviral Activity of Ⅰ Phase of StudyCompletedNCT05391360Phase 1
• Efficacy and Safety of Avatrombopag for Treating TCP in HBV-ACLF Patients Receiving ALSS TreatmentStatus unknownNCT05382013Phase 4
• Possible Differences in HCC Course Depending on DAA TreatmentStatus unknownNCT05376943
• Treatment of Hepatitis c by Using Direct-acting AntiviralStatus unknownNCT05372874
• The Study on Optimal Treatment and Clinical Outcome of Chronic Hepatitis B Patients With Inactive HypoviremiaStatus unknownNCT05357235
• The Study on Clinical Outcome and Treatment Optimization of Chronic Hepatitis B Patients With HypoviremiaStatus unknownNCT05357183
• Efficacy and Safety of Ricovir® in Maintaining Durability of Viral Response in Chronic Hepatitis B Patients Who Have Been Treated With Viread® and Have Undetectable HBV DNA in SerumCompletedNCT05355467Phase 4
• Discontinuation of Antiviral Therapy as a Strategy to Cure Hepatitis BActive, not recruitingNCT05328427Not applicable
• Intralesional Versus Intramuscular Hepatitis B Vaccine Immunotherapy for WartsCompletedNCT05326152Phase 1/2
• Steatohepatitis in Chronic Hepatitis BCompletedNCT05317260
• The Effects of Vitamin D and Calcium Supplementation to Parathyroid Hormone in CHB Patients Treated With TDFCompletedNCT05313477Phase 4
• Phase 1 Study of 162, a Novel Neutralizing Antibody Targeting Hepatitis B Surface Antigen, in Healthy Adult SubjectsCompletedNCT05310487Phase 1
• Seroprevalence of Leptospirosis in Val Müstair, SwitzerlandCompletedNCT05300425
• Performance of Novel Simplified Score for Chronic Hepatitis B Treatment Eligibility in ThailandStatus unknownNCT05295914
• Clinical Study to Evaluate the Safety and Efficacy of Switching to Tenofovir Disoproxil From Tenofovir Disoproxil Fumarate in Patients With Chronic Hepatitis BCompletedNCT05286346Phase 4
• The Effect of Education on Drug Compliance and Quality of Life in Hepatitis B PatientsStatus unknownNCT05286216Not applicable
• Fecal Microbiota Therapy in Steroid Ineligible Alcoholic HepatitisStatus unknownNCT05285592Not applicable
• A phase4 Clinical Study to Evaluate the Safety and Efficacy of Switching to Tenofovir Disoproxil From Tenofovir Disoproxil Fumarate in Patients With Chronic Hepatitis BCompletedNCT05282407Phase 4
• Aerobic Exercise Training in Patients With Chronic Hepatitis B and Hepatic SteatosisCompletedNCT05265026Not applicable
• Preparing for the Final Phase of Hepatitis C Elimination. Cairns Final 30%CompletedNCT05264558Phase 4
• Disease Loads and Status of TreatmentStatus unknownNCT05264272
• Safety and Efficacy of Celecoxib Plus Nucleos(t)Ide Analogues on the Hepatitis B Surface Antigen of Virally Suppressed Subjects With Chronic Hepatitis BStatus unknownNCT05256823Phase 2
• A Study of Hepalatide Combined With TAF and PEG-IFN as Finite Treatment of Chronic Hepatitis B PatientsCompletedNCT05244057Phase 2
• A Study of Cetrelimab in Participants With Chronic Hepatitis B Virus InfectionCompletedNCT05242445Phase 1
• A Study of Safety and Efficacy of ATI-2173 and Vebicorvir in Combination With Tenofovir Disoproxil Fumarate in Subjects With Chronic Hepatitis B Virus InfectionTerminatedNCT05238844Phase 2
• Tacrolimus Versus Mycophenolate for Autoimmune Hepatitis Patients With Incomplete Response on First Line TherapyStatus unknownNCT05221411Phase 4
• Continuing Medical Education to Improve Knowledge of Viral Hepatitis B-C in Primary Healthcare WorkersStatus unknownNCT05207163Not applicable
• Peginterferon Alpha-2b Therapy in Chronic Hepatitis Patients With Normal ALT Level and Low ViremiaStatus unknownNCT05203055Phase 1/2
• Utilization of MAsS in Patients Undergoing LT for HCCTerminatedNCT05184283
• Testing and Epidemiology of Delta HepatitisStatus unknownNCT05181956
• Preventing Mother-to-child Transmission of Hepatitis B Virus With Tenofovir Alafenamide (TAF)Status unknownNCT05177926Phase 4
• Long Term Follow up of Chronic HCV Patients Receiving DAASStatus unknownNCT05170490
• Development of Non-Invasive MRI Applications for Liver Fibrosis and InflammationCompletedNCT05168982
• Effect of Entecavir Versus Tenofovir on HBV DNA Level in Peripheral Blood Mononuclear CellsStatus unknownNCT05168293
• Evaluation of Hepatitis B Virus (HBV) DNA Test As Point of Care ToolCompletedNCT05144776
• Evaluation of the Efficacy and Safety of the Fixed-dose Combination Sofosdac® 400mg/60mg in Patients With Chronic Hepatitis C (HCV)CompletedNCT05138523
• CytoSorb® in Patients With Acute on Chronic Liver FailureWithdrawnNCT05131230
• A Study of JNJ-73763989, JNJ-64300535, and Nucleos(t)Ide Analogs in Virologically Suppressed, Hepatitis B e Antigen (HBeAg)- Negative Participants With Chronic Hepatitis B Virus InfectionCompletedNCT05123599Phase 1
• Providing PrEP, Hepatitis C Treatment, and MOUD Through Telemedicine at Greensboro SSPCompletedNCT05108935Not applicable
• Study to Evaluate Safety and Efficacy of ASC42 Combined With ETV and PEG-IFN α-2a in Subjects With HBVCompletedNCT05107778Phase 2
• Screening for Hepatitis C Using a Rapid Diagnostic Orientation Test (TROD) in Patients Over 50 Years Old in the Digestive Endoscopy Department of the Europeen Hospital MarseilleStatus unknownNCT05103085
• The Immunogenicity and Persistence of Booster Dose With Hepatitis B Vaccine in College StudentsStatus unknownNCT05099757Phase 4
• Prevention of HCC Using Mobile Phone ApplicationsStatus unknownNCT05094869
• Sofosbuvir/Velpatasvir/Voxilaprevir (SOF/VEL/VOX) for Patients With Hepatitis C Virus InfectionStatus unknownNCT05092074
• Treatment of Chronic Hepatitis C Infection by Ledipasvir/Sofosbuvir in Naïve ChildrenCompletedNCT05091008Phase 2
• Phase 3 Study to Evaluate the Efficacy and Safety of Peginterferon Lambda for 48 Weeks in Patients With Chronic HDVActive, not recruitingNCT05070364Phase 3
• Evaluation of Orthohepevirus C Infection as an Emerging Cause of Zoonotic Origin DiseaseStatus unknownNCT05062967
• Impact of the Sustained Viral Response of Chronic Hepatitis c After Treatment With Direct Action AntiviralsCompletedNCT05062408
• Effects of Plant Sterols and Stanols on Liver InflammationStatus unknownNCT05037890Not applicable
• A Single and Repeated Dose Escalation of RBD1016 in Subjects with Chronic Hepatitis B Virus (HBV) InfectionCompletedNCT05017116Phase 1
• Epidemiology of Hepatitis B, C and D and HIV Along the Maroni River Bordering French Guiana and Suriname (MaHeVi)CompletedNCT05002907
• A Study of ALG-020572 Drug to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics After Single Doses in Healthy Volunteers and Multiple Doses in CHB SubjectsTerminatedNCT05001022Phase 1
• Stop Hep B @ BirthStatus unknownNCT04998838Not applicable
• The Efficacy and Safety of 12-week SOF/VEL Regimen Combined With Prophylactic Use of TAF for Treatment-naïve Genotype 1-6 HCV/HBV Co-infection Adult Patients With or Without Compensated Cirrhosis in ChinaStatus unknownNCT04997564Phase 4
• Effort to Narrow the Gap Between in Accordance With Guidelines and Consent to Treat CHB Population in East of ChinaStatus unknownNCT04980664Not applicable
• CARES-HCV: Promoting Screening Uptake Among Diverse Baby BoomersCompletedNCT04980157
• Phase 1 Study of GSK3228836 Pharmacokinetics in Participants With Hepatic ImpairmentCompletedNCT04971928Phase 1
• A 2 PART STUDY EVALUATING EDP-721 IN HEALTHY SUBJECTS AND EDP-721 IN COMBINATION WITH EDP-514 IN PATIENTS WITH CHRONIC HEPATITIS B VIRUS INFECTION.TerminatedNCT04971512Phase 1
• Systematic Screening for Viral Hepatitis B and C at the PASS Consultation of the Montpellier University HospitalStatus unknownNCT04959643
• Effectiveness and Safety of Direct-Acting Antiviral Agents for the Treatment of Chronic Hepatitis CStatus unknownNCT04952207
• Project MATLINK: Development and Evaluation of a Screening, Brief Intervention, & Referral to Treatment (SBIRT) Program for Opioid Dependent Prisoners and Probationers Transitioning to the CommunityCompletedNCT04947475Not applicable
• Regression of Liver Fibrosis by Tenofovir Alafenamide (TAF)Active, not recruitingNCT04939441Phase 4
• A Randomised Clinical Trial Assessing the Efficacy and Safety of Mycophenolate Mofetil Versus Azathioprine for Induction of Remission in Treatment Primary Biliary Cholangitis-Autoimmune Hepatitis Overlap SyndromeStatus unknownNCT04933292Phase 4
• Hepatitis C in Severe Mental Disorders: Nursing ProgrammeCompletedNCT04891445Not applicable
• Molecular Epidemiology of Hepatitis B in Cayenne General Hospital, French GuianaStatus unknownNCT04886102
• 8- Versus 12-week of Sofosbuvir-ravidasvir Treatment of Chronic Hepatitis CCompletedNCT04885855Phase 2/3
• Electronic Record Assimilation and Subsequent Eradication of Hepatitis CCompletedNCT04873609Not applicable
• Hepatitis B Birth Dose for NewbornsCompletedNCT04870021Phase 4
• Study on the Tolerability, Pharmacodynamics and Pharmacokinetics of GST-HG141 TabletsCompletedNCT04868981Phase 1
• Study of VIR-2218, VIR-3434, and/or PEG-IFNα in Subjects With Chronic Hepatitis B Virus InfectionCompletedNCT04856085Phase 2
• Tenofovir Alafenamide to Prevent Perinatal Transmission of Hepatitis BStatus unknownNCT04850950Phase 4
• A Study of Safety and Efficacy of ATI-2173 in Combination With Tenofovir Disoproxil Fumarate in Subjects With Chronic Hepatitis B Virus Infection and in Subjects With Hepatitis D Virus CoinfectionTerminatedNCT04847440Phase 2
• A Study of Peginterferon Alfa-2b Combined With TDF in Patients With Chronic Hepatitis BCompletedNCT04846491Phase 3
• A Cross Sectional Observational Study on Relation Between Oral Manifestation and Hepatitis C in EgyptCompletedNCT04812990
• Prisons Evaluation of a One-stop-shop InterVentiOnCompletedNCT04809246Not applicable
• Plant Stanols and Liver Inflammation in Overweight and Obese ChildrenStatus unknownNCT04783116Not applicable
• Effectiveness of Antiviral Treatment in Cirrhotic Patients with Low-level Hepatitis B Virus DNA LevelsActive, not recruitingNCT04780204Phase 4
• COIN-B: COntrolled Interruption of Nucleos(t)Ide Analogue Treatment in Chronic Hepatitis B InfectionsActive, not recruitingNCT04779970Not applicable
• The Pharmacokinetics of P1101 + Ribavirin in Interferon Treatment-Naïve Subjects With Chronic Hepatitis C Virus (HCV) Genotype 2 InfectionCompletedNCT04774107Phase 1
• HCV Reinfection in in HIV/HCV-coinfected Patients Achieving SVR by Antiviral TherapyStatus unknownNCT04768517
• Evaluation of Liver Fibrosis With 2D-Shear Wave ElastographyCompletedNCT04759521
• Does Hepatitis C Management Protect Egyptian Population Against Severe Corona Virus Disease-2019?CompletedNCT04757272
• Increasing HCV Linkage to Care Among People Who Inject DrugsCompletedNCT04741750Not applicable
• HCV Reinfection in HD Patients Achieving SVRStatus unknownNCT04732832
• Real World Study About Anti-viral Regimen Adjustment on Achieving Complete Response in CHB PatientsStatus unknownNCT04724785
• Occult HCV Infection After DAAD Treatment in Haemodialysis PatientsCompletedNCT04719338Not applicable
• Spirulina (FEM-102) Supplement to Chronic Hepatitis B PatientsCompletedNCT04718831Not applicable
• Evaluation of the Use of the GenXpert to Detect Hepatitis C RNAStatus unknownNCT04717856Not applicable
• Radomised Phase II Study of MTL-CEBPA Plus Sorafenib or Sorafenib AloneCompletedNCT04710641Phase 2
• Combined Ribavirin With Sofosbuvir/Velpatasvir/Voxilaprevir in Retreatment of Chronic Hepatitis C Non-respondersCompletedNCT04695769Phase 4
• European Pregnancy and Paediatric Infections Cohort Collaboration: Paediatric ProtocolStatus unknownNCT04677842
• Prevalence of Occult Hepatitis B Virus Infection（OBI） in Subjects With Chronic Hepatitis B（CHB） Family HistoryStatus unknownNCT04672915
• Morbidity and Mortality of Hepatitis E Virus Infections in BelgiumCompletedNCT04670419
• Safety and Efficacy of Different Antiviral Regimens for Hepatitis C Virus RelapseStatus unknownNCT04662138
• Nurse-led Decision Counseling on Hepatocellular Carcinoma ScreeningCompletedNCT04659005Not applicable

← Hepatitis overview